Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, iBio (IBIO) has a market cap of $28.828 million USD. According to our data, iBio is ranked No.8426 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $28.83 M |
25.31%
|
| Dec 31, 2024 | $23.01 M |
78.83%
|
| Dec 29, 2023 | $12.86 M |
-84.43%
|
| Dec 30, 2022 | $82.63 M |
-96.80%
|
| Dec 31, 2021 | $2.58 B |
-47.62%
|
| Dec 31, 2020 | $4.93 B |
320.00%
|
| Dec 31, 2019 | $1.17 B |
-66.67%
|
| Dec 31, 2018 | $3.52 B |
-58.33%
|
| Dec 29, 2017 | $8.45 B |
-55.00%
|
| Dec 30, 2016 | $18.78 B |
-28.57%
|
| Dec 31, 2015 | $26.29 B |
-18.84%
|
| Dec 31, 2014 | $32.40 B |
102.94%
|
| Dec 31, 2013 | $15.96 B |
-45.16%
|
| Dec 31, 2012 | $29.11 B |
-25.30%
|
| Dec 30, 2011 | $38.97 B |
-73.73%
|
| Dec 31, 2010 | $148.37 B |
251.11%
|
| Dec 31, 2009 | $42.26 B |
718.18%
|
| Dec 31, 2008 | $5.16 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
 Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
 Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
 Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
 Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
 Altimmune
ALT
|
$0.49 B |
0.000 M
|
USA
|
 Telesis Bio
TBIO
|
$0.53 M |
0.000 M
|
USA
|
 Emergent BioSolutions
EBS
|
$0.59 B |
0.000 M
|
USA
|
 Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
 Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
USA
|
 Tonix Pharmaceuticals
TNXP
|
$59.62 M |
0.000 M
|
USA
|
| Market Cap | = | IBIO Stock Price | * | IBIO Shares Outstanding |
| = | $3.07 | * | 9.39 M | |
| = | $28.83 M |